[Federal Register: November 10, 2008 (Volume 73, Number 218)]
[Notices]               
[Page 66603]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr10no08-49]                         

-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army

 
Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Provisional Patent Application Concerning Synthetic 
Stereoisomers of Hyperzine A for Protection Against Chemical Warfare 
Agents (CWA), CWA-Induced Seizures, and Other Neurological Seizures

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Announcement is made of the availability for licensing of the 
invention set forth in U.S. Provisional Patent Application Serial No. 
61/104,388 entitled ``Synthetic Stereoisomers of Hyperzine A for 
Protection Against Chemical Warfare Agents (CWA), CWA-Induced Seizures, 
and other Neurological Seizures,'' filed October 10, 2008. The United 
States Government, as represented by the Secretary of the Army, has 
rights in this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research & Technology Assessment, (301) 619-6664, both 
at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: The invention comprises pre and/or post 
exposure treatment of a patient with [+]-Huperzine A for chemical 
warfare nerve agent or organophosphate induced seizure/status 
epilepticus and neuropathology.

Brenda S. Bowen,
Army Federal Register Liaison Officer.
 [FR Doc. E8-26719 Filed 11-7-08; 8:45 am]

BILLING CODE 3710-08-P